Testing for Circulating Tumor Cells (CTCs) [Featured Topic]

The CellSearch Circulating Tumor Cell (CTC) test is a simple blood test that helps oncologists in assessing the prognosis of patients with metastatic breast, colorectal, or prostate cancer. The CellSearch test is the only FDA-approved test for CTC assessment. Each result of the CellSearch test performed at Mayo Clinic is verified by both a cytotechnologist and a pathologist to ensure quality.

Full content can be viewed here.


Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.